The page is the record's research on the issuer — no analyst, no rating, no view. # Minerva Neurosciences, Inc. (NASDAQ: NERV) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Minerva Neurosciences, Inc. is listed on NASDAQ under ticker NERV, with ISIN US6033802058 and LEI 54930017PANCHC5LYH79. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Massachusetts. The segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 79 filings in the window 2025-11-08 to 2026-11-08, across 43 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-06 and is of type results, 2 days before the record date of 2026-11-08. The exchange median cadence gap is 6.0 days, the exchange median filings are 52, and the exchange median latency is 5.0 days, across 4359 NASDAQ issuers. The sector median cadence gap is 6.0 days, the sector median filings are 63.0, and the sector median latency is 4.0 days, across 526 issuers in 2834 Pharmaceutical Preparations. ## Auditor The auditor of record is Deloitte & Touche LLP, located in Boston, Massachusetts. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage Three research houses are named on the issuer's investor-relations page: H.C. Wainwright, Jefferies and Citizens. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0001598646.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/NERV (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1598646/000119312526101117/nerv-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://minervaneurosciences.com/investors/stock-information/ (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/NERV (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/NERV · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp